Diphenhydramine citrate
- Level
- Commodity
- Parent
- 51312300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51312308This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4OD433S209. European Medicines Agency schedules Diphenhydramine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01768MIG. Diphenhydramine citrate generally arises in the molecular formula C17H21NO.C6H8O7. The term 'diphenhydramine citrate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule diphenhydramine citrate under HS 29221980 and SITC 51461. As of Q4 2014, DIPHENHYDRAMINE CITRATE remains US FDA's Preferred Term for this commodity. Diphenhydramine citrate bears US NLM identifiers UMLS ID C0282144 and NCI Concept Code C82274. SMILES: CN(C)CCOC(C1CCCCC1)C2CCCCC2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51312300 · 15Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.